15
Participants
Start Date
July 26, 2021
Primary Completion Date
April 23, 2024
Study Completion Date
National Hospital Organization Tokyo Medical Center, Tokyo
Lead Sponsor
Janssen Pharmaceutical K.K.
INDUSTRY